Frederic Boned - 08 Feb 2024 Form 4 Insider Report for BALCHEM CORP (BCPC)

Role
SVP/GM, Human Nutri. & Health
Signature
/s/ Travis Larsen, Attorney in Fact for Frederic Boned
Issuer symbol
BCPC
Transactions as of
08 Feb 2024
Net transactions value
$0
Form type
4
Filing time
12 Feb 2024, 19:05:43 UTC
Previous filing
10 Feb 2023
Next filing
11 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCPC Common Stock Award $0 +1,380 +35% $0.000000 5,322 08 Feb 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCPC Stock Option Award $0 +4,500 $0.000000 4,500 08 Feb 2024 Common Stock 4,500 $143.43 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
F2 Includes acquisition of shares under the Balchem Corporation 401(k) plan.
F3 Options vest 20% Year 1; 40% Year 2: and 40% Year 3.